Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Keswani Sanjay Chandru, holds the title of Chief Medical Officer at NEUROCRINE BIOSCIENCES INC.
On 2026-09-11, the insider transacted 6,026 shares.The shares were transacted at a weighted average price of $54.75 per share, resulting in a total market-relevant value of $330K.
Keswani Sanjay Chandru (Chief Medical Officer) had withheld for taxes $330K of $NBIX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.